| Hypoxic group (n = 18) | Normoxic group (n = 16) | p-value |
---|---|---|---|
Gender (m, f) | m 5 (28%) / f 13 (72%) | m 2 (12.5%) / f 14 (87.5%) | 0.25b |
Age (years) | 80.89 (7.87) | 83.44 (5.5) | 0.14 |
Height (cm) | 163.72 (8.29) | 163.19 (8.52) | 0.43 |
Weight (kg) | 72.03 (9.32) | 66.83 (12.27) | 0.09 |
BMI (kg/m2) | 26.98 (3.91) | 25.02 (3.62) | 0.07 |
MMSE score | 24.94 (3.75) | 24.5 (3.93) | 0.36 |
Therapy days (n) | 18.33 (2.43) | 17.5 (2.58) | 0.16c |
Arterial oxygen saturation (%) | 94.21 (6.19) | 93.65 (7.54) | 0.42 |
Minimum oxygen saturation (%)a | 81.39 (2.8) | 83.85 (5.51) | 0.27c |
Regular medication, n (%) | |||
 Anticoagulants | 9 (50%) | 10 (62.5%) | 0.35b |
 ß-blockers | 7 (38.9%) | 8 (50%) | 0.38b |
 ACE inhibitors | 7 (38.9%) | 6 (37.5%) | 0.61b |
 AT II inhibitors | 6 (33.3%) | 3 (18.8%) | 0.29b |
 Calcium channel blockers | 5 (27.8%) | 1 (6.3%) | 0.12b |
 Statins | 1 (5.6%) | 4 (25%) | 0.13b |
 Diuretics | 8 (44.4%) | 9 (56.3%) | 0.37b |
 Nitrates | 1 (5.6%) | 1 (6.3%) | 0.73b |